Key Takeaways
- RBC Capital Markets boosted its 12-month S&P 500 price objective to 7,900 from a prior 7,750
- This revised forecast suggests potential upside of 7.7% from Thursday’s closing level of 7,335.66
- The firm highlights a “two-speed economy” where AI companies thrive while others struggle with challenges
- Healthcare sector rating dropped to Market Weight amid declining earnings revisions and investor outflows
- Key concerns include elevated semiconductor valuations and ongoing Middle East tensions
On Friday, RBC Capital Markets announced an increased S&P 500 price objective of 7,900, moving up from its previous 7,750 forecast. Lori Calvasina, who leads U.S. strategy at RBC, established this updated benchmark.
This target adjustment follows the S&P 500’s impressive surge of over 16% since hitting its March 30 bottom. With Thursday’s session ending at 7,335.66, the fresh projection indicates approximately 7.7% potential appreciation from current levels.
RBC’s methodology relies on its valuation and earnings-per-share framework instead of averaging its five different forecasting approaches. The strategists explained this particular model offers superior insight into what they describe as a “two-speed economy.”
This concept describes a market bifurcation where artificial intelligence-focused businesses deliver robust earnings performance, while other segments contend with headwinds from the continuing Middle East crisis.
The firm applied a 5% reduction to bottom-up EPS projections for Q1 2027, resulting in approximately $329 per share. AI-sector estimates remained unchanged from consensus views, whereas projections for other index components received a 7.5% haircut.
Economic Framework Supporting the Forecast
Regarding macroeconomic variables, RBC incorporated an inflation rate of 3.3%, exceeding consensus expectations. The analysis also assumes the Federal Reserve will maintain current interest rates while 10-year Treasury yields hover around 4.5%.
These parameters generated an implied trailing P/E ratio of approximately 24 times earnings.
RBC acknowledged that calculating the mean of all five forecasting models yields a more bullish 8,100 target. Nevertheless, the firm selected 7,900 as its formal projection, asserting it more accurately balances both potential rewards and existing hazards.
This adjustment mirrors comparable upgrades from J.P. Morgan and Barclays during the previous month. Both institutions pointed to diminishing geopolitical tensions and strengthening earnings trends as justification for their revisions.
RBC maintained its preference for growth versus value stocks among large-capitalization equities. The firm also continues favoring domestic equities over international alternatives while expressing cautious optimism toward small-cap stocks.
Healthcare Sector Rating Reduced
Alongside raising its index target, RBC implemented a sector-level modification. The firm lowered its stance on U.S. healthcare equities to Market Weight from the previous Overweight rating.
This downgrade stems from worsening earnings estimate trends, substantial fund redemptions, and disappointing findings in RBC’s latest analyst survey.
RBC identified multiple threats to its market outlook. These encompass possible downward adjustments to 2027 EPS forecasts and excessive valuations throughout the semiconductor industry.
The firm characterized the Middle East situation as the primary tail risk capable of triggering a U.S. economic contraction. However, strategists noted that most publicly traded corporations have indicated they can navigate the current disruptions.
Last month, the S&P 500 recorded its strongest monthly percentage advance since November 2020.
